Aptamer-Nanoparticle Bioconjugates for Drug Delivery

Drug delivery systems traditionally relied on passive diffusion mechanisms for targeting

and releasing of therapeutically active molecules. The major problems associated with

traditional delivery are poor specificity and dose-limited toxicity. Nanoparticles have found

applicability in the development of novel drug delivery systems by easily overcoming

toxicity problem. However, specificity of …